AMERICAN SOCIETY FOR RADIATION ONCOLOGY for AMERICAN SOCIETY FOR RADIATION ONCOLOGY
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Veterans VET
Review of brachytherapy treatments at Philadelphia VA and testimony to promote brachytherapy as a safe cancer treatment option.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Medicare/Medicaid MMM
Support for legislation to rebase the Medicare physician payment formula to stabilize physician payments, including support for the Medicare Physician Fairness Act of 2009 (S. 1776). Advocacy to stop the 19 percent cut for radiation oncology services proposed by CMS in the 2010 proposed physician fee schedule. Support for legislation to insure patient safety and preserve the integrity of the Medicare program by ending abuses of the physician self-referral law for radiation therapy services. Comprehensive Cancer Care Improvement Act of 2009 (H.R. 1844) to expand cancer care planning, comprehensive symptom management and to authorize demonstrations for hospice and palliative care for cancer patients. Legislation to support structural changes that lead to delivering high-quality care for patients while increasing efficiencies and promoting Medicare sustainability; oppose radiation oncology benefit managers. Support for H.R. 3095 to provide Medicare coverage for cancer patients.
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Health Issues HCR
Support for the Access to Cancer Clinical Trials Act of 2009 (S. 488, H.R. 716) to provide access to clinical trials for cancer patients. Support for the 21st Century Cancer ALERT bill (S. 717) to modernize cancer research, increase access to preventative cancer services, provide cancer treatment and survivorship initiatives, and for other purposes. Support for health care reform provisions in the America's Healthy Future Act (H.R. 3200) and the Affordable Health Choices Act (S. 1796) to reform health care through a combination of public and private approaches to cover medically necessary services; support review and development of national workforce strategy; support elimination of pre-existing condition limitations; support medical liability reform; support consumer protection from annual and lifetime insurance limits; provide funding for comparative effectiveness research; and support expanded access to and use of regular health assessments and preventive services, including early screening and detection. Support a definition for meaningful use of health care technology that allows specialty physicians to benefit from incentive payments for the use of specialty-specific products. Support funding for the development of domestic medical isotope production, specifically American Medical Isotope Production Act of 2009 (H.R. 3276). Support for increasing cancer research funding, including support for the Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act for FY 2010 (H.R. 3293).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Homeland Security HOM
To protect access to medical isotopes used in cancer treatments such as brachytherapy and stereotactic radiosurgery. Development of domestic medical isotope production, specifically the American Medical Isotope Production Act of 2009 (H.R. 3276).
| Lobbyist | Covered position, as disclosed |
|---|---|
| DAVID ADLER | — |
| RICHARD J MARTIN | — |
| EMILY WILSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.